All data are based on the daily closing price as of July 18, 2024
k

Korea United Pharm

033270.KO
17.40 USD
-0.05
-0.29%

Overview

Last close
17.40 usd
Market cap
255.91M usd
52 week high
22.43 usd
52 week low
15.77 usd
Target price
26.76 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.0549
Price/Book Value
0.876
Enterprise Value
262.68M usd
EV/Revenue
0.7924
EV/EBITDA
3.0785

Key financials

Revenue TTM
116.77M usd
Gross Profit TTM
58.58M usd
EBITDA TTM
22.04M usd
Earnings per Share
N/A usd
Dividend
0.3 usd
Total assets
361.57M usd
Net debt
N/A usd

About

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
  • Symbol
    033270.KO
  • Exchange
    KO
  • Isin
    KR7033270000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.kup.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top